Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Accretion Pharmaceuticals Ltd
Registered Office: 29 Xcelon Ind Park 1,Vasna Chacharvadi Sanand , Ahmedabad - 382213 , Gujarat , India.
Phone : +91 97148 82929   Fax:
Email :  care@accretionpharma.com  
Website :  http://www.accretionpharma.com
Initial public offer of upto 29,46,000 equity shares of face value of 10/- each (the equity shares) of Accretion Pharmaceuticals Limited (the company or accretion or the issuer) at an issue price of [*] per equity share for cash, aggregating up to [*] crores (public issue) out of which 1,47,600 equity shares of face value of 10 each, at an issue price of [*] per equity share for cash, aggregating [*] crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e., issue of 27,98,400 equity shares of face value of 10 each, at an issue price of[*] per equity share for cash, aggregating upto [*] crores is herein after referred to as the net issue. The public issue and net issue will constitute 26.50% and 25.17% respectively of the post-issue paid-up equity share capital of our company. Price Band: 96 to 101 per equity share of the face value of 10 each. The floor price is 9.6 times of the face value of the equity shares and the cap price is 10.1 times of the face value of the equity shares. Bids can be made for a minimum of 1200 equity shares and in multiples of 1200 equity shares thereafter.

Issue Money Payable On
Opens On Closes On Application Allotment
14-May-25 16-May-25 Rs96.00-101.00 Rs0.00-0.00
Minimum Application for shares in Nos :1200  Further Multiples of :1200

  RsCr Lead Managers to the Issue
Project Cost 0.00
Jawa Capital Services Pvt Ltd
Project Financed through Current Offer 28.28  
Post Issue Equity Share Capital 11.12  
Issue Price Rs96.00  
 
Projects
 Capital expenditure towards purchase of new equipment/machineries, etc Repayment/prepayment of certain borrowings availed by the company
 Capital expenditure towards upgradation of existing mfg facility Funding working capital requiremnts
 Expenditure in connection with product registration in overseas market General corporate purposes
Promoted By
 Harshad Nanubhai Rathod
 Vivek Ashok Kumar Patel
 Mayur Popatlal Sojitra
Listing At
 NSE - SME 
Registrar to the Issue
 KFin Techologies Ltd